Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up

BACKGROUND: Patients with systemic sclerosis (SSc) have poor prognosis without cure methods. We began, 10 years ago, to relieve active SSc using short-term intravenous high-dose methylprednisolone pulse (MP-Pulse) and then maintain remission using long-term and low-dose oral glucocorticoids (LTLD-GC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hao, Yu, Zhen, Yan, Cheng-lan, Yang, Hui-dan, Gao, Chong, Wen, Hong-yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359792/
https://www.ncbi.nlm.nih.gov/pubmed/35958185
http://dx.doi.org/10.2147/JIR.S373387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359792/
https://www.ncbi.nlm.nih.gov/pubmed/35958185
http://dx.doi.org/10.2147/JIR.S373387

Ejemplares similares